G1 Therapeutics, Inc.

GTHXDelisted Sep 18, 2024

Industry: Pharmaceutical Preparations
SEC CIK: 0001560241

SEC filings (opens in a new tab)

G1 Therapeutics, Inc. was delisted on Sep 18, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 88 institutions reported holding it in 13F filings for Q2 2024, worth $45.5M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding G1 Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of GTHX: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Of which not filed for Q3 2022	Q3 2022	Change
Holders	98	1	104	+7
Shares	19.9M	3.66K	23.1M	+3.21M (+16.2%)
Value	$98.2M	$18.0K	$287.5M	+$189.3M (+192.9%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held G1 Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to GTHX in Q3 2022
Institution	Shares	Value	% of portfolio
Paradigm Biocapital Advisors LP	884,574	$11.0M	1.56%
Adage Capital Partners GP, L.L.C.	346,000	$4.32M	0.01%
Voloridge Investment Management, LLC	328,800	$4.11M	0.02%
Norges Bank	225,700	$2.82M	0.00%
EAM Investors, LLC	223,654	$2.79M	0.61%
Rafferty Asset Management, LLC	137,472	$1.72M	0.02%
EAM Global Investors LLC	133,203	$1.66M	0.44%
Occudo Quantitative Strategies LP	116,303	$1.45M	0.11%
Barclays PLC	113,631	$1.42M	0.00%
Invesco Ltd.	113,061	$1.41M	0.00%
Graham Capital Management, L.P.	94,340	$1.18M	0.05%
Schonfeld Strategic Advisors LLC	91,523	$1.14M	0.01%
AE Wealth Management LLC	44,005	$550.0K	0.00%
Alpha DNA Investment Management LLC	42,477	$530.0K	0.46%
Magnus Financial Group LLC	25,000	$312.0K	0.06%
BIT Capital GmbH	23,199	$289.8K	0.06%
Simplex Trading, LLC	19,501	$243.0K	0.01%
Susquehanna Fundamental Investments, LLC	18,100	$226.0K	0.00%
Dynamic Technology Lab Private Ltd	14,901	$186.0K	0.02%
Creative Financial Designs Inc	12,000	$150.0K	0.02%
US Bancorp	2,736	$34.0K	0.00%
Macroview Investment Management LLC	819	$10.0K	0.02%
Dark Forest Capital Management LP	502	$6.00K	0.00%
China Universal Asset Management Co., Ltd.	401	$5.00K	0.00%
Parallel Advisors, LLC	50	$1.00K	0.00%

Sold out (18)

Institutions that held G1 Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of GTHX in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Ergoteles LLC	220,100	$1.09M
Federated Hermes, Inc.	179,472	$887.0K
State of Wisconsin Investment Board	131,600	$650.0K
Kennedy Capital Management, Inc.	72,347	$357.0K
Balyasny Asset Management LLC	28,394	$140.0K
Ensign Peak Advisors, Inc	25,220	$125.0K
Bayesian Capital Management, LP	23,800	$118.0K
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors	14,195	$118.0K
Caxton Associates LP	21,388	$106.0K
HSBC Holdings PLC	17,578	$87.0K
Y-Intercept (Hong Kong) Ltd	17,100	$84.0K
Laurion Capital Management LP	12,656	$63.0K
Centiva Capital, LP	11,737	$58.0K
Golden Green, Inc.	11,220	$55.0K
Envestnet Asset Management Inc	10,772	$53.0K
High Net Worth Advisory Group LLC	1,000	$5.00K
New York State Common Retirement Fund	266	$1.00K
Credit Suisse AG	1	$0

Not filed for Q3 2022 yet (1)

Institutions that held G1 Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding GTHX in Q2 2022 that haven't filed for Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Urban Wealth Management, LLC	3,658	$18.0K